TY - JOUR
T1 - Thymus Functionality Needs More Than a Few TECs
AU - Bhalla, Pratibha
AU - Su, Dong Ming
AU - van Oers, Nicolai S.C.
N1 - Funding Information:
Our work was supported, in part, by grants from the National Institutes of Health. National Institutes of Health grant R01AI114523 (NvO) National Institutes of Health grant R21AI144140 (NvO).
Funding Information:
We sincerely appreciate insights into human thymus hypoplasia’s from our discussions with Drs. Christian Wysocki (UT Southwestern Medical Center), Maria Teresa de la Morena (Seattle Children’s and the University of Washington) and Mary Louise Markert (Duke University Medical Center), clinicians who care for patients with diverse in-born errors of immunity.
Publisher Copyright:
Copyright © 2022 Bhalla, Su and van Oers.
PY - 2022/6/10
Y1 - 2022/6/10
N2 - The thymus, a primary lymphoid organ, produces the T cells of the immune system. Originating from the 3rd pharyngeal pouch during embryogenesis, this organ functions throughout life. Yet, thymopoiesis can be transiently or permanently damaged contingent on the types of systemic stresses encountered. The thymus also undergoes a functional decline during aging, resulting in a progressive reduction in naïve T cell output. This atrophy is evidenced by a deteriorating thymic microenvironment, including, but not limited, epithelial-to-mesenchymal transitions, fibrosis and adipogenesis. An exploration of cellular changes in the thymus at various stages of life, including mouse models of in-born errors of immunity and with single cell RNA sequencing, is revealing an expanding number of distinct cell types influencing thymus functions. The thymus microenvironment, established through interactions between immature and mature thymocytes with thymus epithelial cells (TEC), is well known. Less well appreciated are the contributions of neural crest cell-derived mesenchymal cells, endothelial cells, diverse hematopoietic cell populations, adipocytes, and fibroblasts in the thymic microenvironment. In the current review, we will explore the contributions of the many stromal cell types participating in the formation, expansion, and contraction of the thymus under normal and pathophysiological processes. Such information will better inform approaches for restoring thymus functionality, including thymus organoid technologies, beneficial when an individuals’ own tissue is congenitally, clinically, or accidentally rendered non-functional.
AB - The thymus, a primary lymphoid organ, produces the T cells of the immune system. Originating from the 3rd pharyngeal pouch during embryogenesis, this organ functions throughout life. Yet, thymopoiesis can be transiently or permanently damaged contingent on the types of systemic stresses encountered. The thymus also undergoes a functional decline during aging, resulting in a progressive reduction in naïve T cell output. This atrophy is evidenced by a deteriorating thymic microenvironment, including, but not limited, epithelial-to-mesenchymal transitions, fibrosis and adipogenesis. An exploration of cellular changes in the thymus at various stages of life, including mouse models of in-born errors of immunity and with single cell RNA sequencing, is revealing an expanding number of distinct cell types influencing thymus functions. The thymus microenvironment, established through interactions between immature and mature thymocytes with thymus epithelial cells (TEC), is well known. Less well appreciated are the contributions of neural crest cell-derived mesenchymal cells, endothelial cells, diverse hematopoietic cell populations, adipocytes, and fibroblasts in the thymic microenvironment. In the current review, we will explore the contributions of the many stromal cell types participating in the formation, expansion, and contraction of the thymus under normal and pathophysiological processes. Such information will better inform approaches for restoring thymus functionality, including thymus organoid technologies, beneficial when an individuals’ own tissue is congenitally, clinically, or accidentally rendered non-functional.
KW - FOXN1
KW - T cell development
KW - endothelial cells
KW - mesenchymal cells
KW - thymus
KW - thymus epithelial cells
KW - thymus organoid technologies
KW - thymus regeneration
UR - http://www.scopus.com/inward/record.url?scp=85133101649&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133101649&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2022.864777
DO - 10.3389/fimmu.2022.864777
M3 - Review article
C2 - 35757725
AN - SCOPUS:85133101649
SN - 1664-3224
VL - 13
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 864777
ER -